Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease

Details for Australian Patent Application No. 2009256558 (hide)

Owner Alize Pharma

Inventors Brizzi, Maria Felice; Ghigo, Ezio; Muccioli, Giampiero

Agent Watermark

Pub. Number AU-A-2009256558

PCT Pub. Number WO2009/150214

Priority 61/061,163 13.06.08 US

Filing date 12 June 2009

Wipo publication date 17 December 2009

International Classifications

A61K 38/25 (2006.01) Medicinal preparations containing peptides - Growth hormone-releasing factor (GH-RF) (Somatoliberin)

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 17/00 (2006.01) Drugs for dermatological disorders

Event Publications

13 January 2011 PCT application entered the National Phase

  PCT publication WO2009/150214 Priority application(s): WO2009/150214

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009256561-Overalls for cleanroom and the like

2009256556-Water-soluble amine and uses thereof